Literature DB >> 4977284

Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state.

E C Gotschlich, I Goldschneider, M S Artenstein.   

Abstract

Purified meningococcal polysaccharides were administered to army recruits. No adverse reactions were observed in 145 men who received group C polysaccharide, and in 53 men who were injected with group A polysaccharide. Hemagglutinating and bactericidal activity developed in the sera of all individuals with the exception of two recruits injected with A polysaccharide. During the 6 wk period of observation, the proportion of unvaccinated recruits who acquired group C meningococci in the three companies studied was 38, 42, and 69 per cent. A significantly lower proportion of the individuals vaccinated with group C polysaccharide acquired group C meningococci; 4.6, 24, and 31 per cent respectively.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4977284      PMCID: PMC2138662          DOI: 10.1084/jem.129.6.1385

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  IDENTIFICATION OF THE ANTIVIRAL SUBSTANCES IN NASAL SECRETIONS.

Authors:  M S ARTENSTEIN; J A BELLANTI; E L BUESCHER
Journal:  Proc Soc Exp Biol Med       Date:  1964-11

2.  Antibody formation after injection of heterologous immune globulin. II. Competition of antigens.

Authors:  F L ADLER
Journal:  J Immunol       Date:  1957-03       Impact factor: 5.422

3.  Studies on immunity to streptococcal infections in man.

Authors:  L W WANNAMAKER; F W DENNY; W D PERRY; A C SIEGEL; C H RAMMELKAMP
Journal:  AMA Am J Dis Child       Date:  1953-09

4.  THE INACTIVATION OF EPIDEMIC INFLUENZA VIRUS BY NASAL SECRETIONS OF HUMAN INDIVIDUALS.

Authors:  T Francis
Journal:  Science       Date:  1940-02-23       Impact factor: 47.728

5.  Sulfadiazine-resistant group A Neisseria meningitidis.

Authors:  C E Alexander; W R Sanborn; G Cherriere; W H Crocker; P E Ewald; C R Kay
Journal:  Science       Date:  1968-09-06       Impact factor: 47.728

6.  CHARACTERISTICS OF AN IMMUNE SYSTEM COMMON TO CERTAIN EXTERNAL SECRETIONS.

Authors:  T B TOMASI; E M TAN; A SOLOMON; R A PRENDERGAST
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

7.  Human immunity to the meningococcus. II. Development of natural immunity.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

8.  Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.

Authors:  E C Gotschlich; I Goldschneider; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

9.  PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES.

Authors:  C M Macleod; R G Hodges; M Heidelberger; W G Bernhard
Journal:  J Exp Med       Date:  1945-11-30       Impact factor: 14.307

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  51 in total

1.  Pattern of bacterial meningitis in Italy, 1994.

Authors:  S Salmaso; P Mastrantonio; G Scuderi; M E Congiu; T Stroffolini; M G Pompa; S Squarcione
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

Review 2.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec, Canada.

Authors:  P De Wals; M Dionne; M Douville-Fradet; N Boulianne; J Drapeau; G De Serres
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

4.  Structure of Neisseria meningitidis lipoprotein GNA1162.

Authors:  Xiangyu Cai; Jing Lu; Zhenhua Wu; Chunting Yang; Honglin Xu; Zhijie Lin; Yuequan Shen
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-03-28

5.  Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.

Authors:  Q Zhang; R Lakshman; R Burkinshaw; S Choo; J Everard; S Akhtar; A Finn
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.

Authors:  E L Anderson; T Bowers; C M Mink; D J Kennedy; R B Belshe; H Harakeh; L Pais; P Holder; G M Carlone
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 7.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

8.  The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man.

Authors:  R B Roberts
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

9.  Acquired and natural immunity to gonococcal infection in chimpanzees.

Authors:  S J Kraus; W J Brown; R J Arko
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

10.  Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens.

Authors:  J Melancon; R A Murgita; I W Devoe
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.